In vitro, pharmacological inhibition of G6PD using 6-AN was found to significantly reduce proliferation; notably, the reduction in prostate cancer cell viability was greater when cells were cultured in the presence of bone marrow stromal cells. This evidence concerns the gene G6PD and prostate carcinoma.